Supexa-OD 60 Tablet

For maximum protection against stroke or clot recurrence, Supexa-OD 60 Tablet should be taken as directed, at the same time each day. Stopping the medication abruptly or skipping doses could raise the risk of dangerous blood clots. When a dose is forgotten, take it as soon as possible on the same day, but avoid doubling up. Follow-up visits and checks for signs of bleeding or clotting should be conducted during therapy.

Common side effects of Supexa-OD 60 Tablet include bleeding, rash, anemia, and increased liver tests. If you have concerns about these effects or experience any unusual symptoms, consult your doctor for guidance.

Supexa-OD 60 Tablet is contraindicated in patients with pathologically active bleeding, including gastrointestinal bleeding or recent hemorrhagic stroke. It must not be administered in patients with a mechanical heart valve or in moderate to severe mitral stenosis since it is not established in its safety and effectiveness in these conditions. Caution is exercised in patients with severe renal impairment or hepatic illness with coagulopathy, in whom bleeding risk is higher. Supexa-OD 60 Tablet must not also be started in patients with CrCl >95 mL/min when given for nonvalvular atrial fibrillation, as a decrease in the efficacy of preventing stroke exists.